Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Bhatnagar

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Fertility and Sterility|February 1, 1973
Effect of oral diethylstilbestrol on plasma progesteroneJ A Board, A S Bhatnagar, C W Bush
Journal of Reproduction and Fertility. Supplement|January 1, 1996
Use of a specific aromatase inhibitor for determining whether there is a role for oestrogen in follicle/oocyte maturation, ovulation and preimplantation embryo developmentN R Moudgal, G Shetty, N Selvaraj, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitorA S Bhatnagar, A Häusler, K Schieweck, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1994
Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liverH S Purba, E J King, P Richert, et al.
Obstetrics and Gynecology|January 1, 1980
Timed 12-hour specimens in outpatient estriol monitoringS E Davis, J Hansen, A S Bhatnagar, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patientsP F Trunet, A S Bhatnagar, H A Chaudri, et al.
Journal of Steroid Biochemistry|July 1, 1989
An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitorsA Häusler, L Schenkel, C Krähenbühl, et al.
American Journal of Obstetrics and Gynecology|November 1, 1974
Use of laboratory and clinical factors in the management of pregnancies complicated by maternal diseaseL J Dunn, C Bush, S E Davis, et al.
The Journal of Endocrinology|September 1, 1994
Effect of blocking oestrogen synthesis with a new generation aromatase inhibitor CGS 16949A on follicular maturation induced by pregnant mare serum gonadotrophin in the immature ratN Selvaraj, G Shetty, K Vijayalakshmi, et al.
American Journal of Obstetrics and Gynecology|February 1, 1977
Effects of alpha- and beta-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrheaJ A Board, R J Fierro, A J Wasserman, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Fertility and Sterility|February 1, 1973
Effect of oral diethylstilbestrol on plasma progesteroneJ A Board, A S Bhatnagar, C W Bush
Journal of Reproduction and Fertility. Supplement|January 1, 1996
Use of a specific aromatase inhibitor for determining whether there is a role for oestrogen in follicle/oocyte maturation, ovulation and preimplantation embryo developmentN R Moudgal, G Shetty, N Selvaraj, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitorA S Bhatnagar, A Häusler, K Schieweck, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1994
Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liverH S Purba, E J King, P Richert, et al.
Obstetrics and Gynecology|January 1, 1980
Timed 12-hour specimens in outpatient estriol monitoringS E Davis, J Hansen, A S Bhatnagar, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patientsP F Trunet, A S Bhatnagar, H A Chaudri, et al.
Journal of Steroid Biochemistry|July 1, 1989
An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitorsA Häusler, L Schenkel, C Krähenbühl, et al.
American Journal of Obstetrics and Gynecology|November 1, 1974
Use of laboratory and clinical factors in the management of pregnancies complicated by maternal diseaseL J Dunn, C Bush, S E Davis, et al.
The Journal of Endocrinology|September 1, 1994
Effect of blocking oestrogen synthesis with a new generation aromatase inhibitor CGS 16949A on follicular maturation induced by pregnant mare serum gonadotrophin in the immature ratN Selvaraj, G Shetty, K Vijayalakshmi, et al.
American Journal of Obstetrics and Gynecology|February 1, 1977
Effects of alpha- and beta-adrenergic blocking agents on serum prolactin levels in women with hyperprolactinemia and galactorrheaJ A Board, R J Fierro, A J Wasserman, et al.
Pageof 6